AbbVie (ABBV) Pressed by Senator Wyden on How U.S. Humira Sales Limit Taxes - Bloomberg
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
AbbVie's Humira gets a US rival, but costs could stay high, Health News, ET HealthWorld
Frontiers | The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
Cost and Humira: Financial assistance options, savings, more
HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India
A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive
FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high | Nasdaq